BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 3010492)

  • 1. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
    Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
    Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 4. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
    Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
    Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.
    Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G
    Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of heparin on platelet aggregation in vitro].
    RĂ³ka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.
    Sweatt JD; Johnson SL; Cragoe EJ; Limbird LE
    J Biol Chem; 1985 Oct; 260(24):12910-9. PubMed ID: 2997148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.